Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
Maersk-Moller Kimberly
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-06-24
|
3. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [MDXG]
|
|
(Last)
|
(First)
|
(Middle)
|
|
1775 WEST OAK COMMONS COURT
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
Chief Commercial Officer /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
|
MARIETTA
|
GA
|
30062
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Maersk-Moller Kimberly
1775 WEST OAK COMMONS COURT
MARIETTA, GA30062
|
|
|
Chief Commercial Officer
|
|
Signatures
|
/s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller
|
2024-07-03
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
This filing is made on behalf of a new executive officer to report their existing holdings of MiMedx Securities.
|
|
(2)
|
Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 2, 2022, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
|
|
(3)
|
Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 13, 2023, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
|
|
(4)
|
Reflects grant of restricted stock units which vests fully on the third anniversary of the grant from the original grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
|
|
(5)
|
The options granted to the reporting person shall vest 25% on each anniversary of the grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
MiMedx Group Inc.